Dingdang Health (09886) announced interim results. Shareholders' losses of 64.371 million yuan increased 24.6% year over year

According to the Zhitong Finance App, Dingdang Health (09886) announced the interim results for the six months ended June 30, 2026. The group obtained revenue of RMB 2,409 billion (same unit), an increase of 3.5% over the previous year; losses during the period were attributable to the owners of the Company of 643.71 million yuan, an increase of 24.6% over the previous year; loss per share was 0.05 yuan.

The announcement said that during the reporting period, increased competition in the industry posed certain challenges to the company's operations, and total revenue still achieved year-on-year growth, mainly due to improvements in the company's overall operating efficiency, product structure optimization, and supply chain service capabilities.